BMS’ and bluebird bio’s Abecma approved by US FDA; first CAR T cell therapy for multiple myeloma Bristol Myers Squibb and bluebird bio, Inc. announced that the US Food and Drug Administration approved Abecma (idecabtagene vicleucel;...
Novartis’ blockbuster Entresto received the US FDA approval for a broader target population Novartis has received the US FDA approval of Entresto ((sacubitril/valsartan) for the broader target population; it is now approved for...
